Sheila Pleite Selgas

Title: Innovations by Sheila Pleite Selgas

Introduction

Sheila Pleite Selgas is a prominent inventor based in Alcobendas-Madrid, Spain. She has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors. With a total of two patents to her name, her work is recognized for its potential impact on treating various diseases.

Latest Patents

Her latest patents include innovative compounds that serve as kinase inhibitors. The first patent focuses on kinase inhibitors of Formula I, which are designed to target specific pathways in cellular processes. The second patent details benzimidazoles and benzothiazoles as inhibitors of MAP kinase, providing compounds that inhibit p-38 kinase. These compounds are particularly useful in the treatment of metastasis and rheumatoid arthritis.

Career Highlights

Sheila is currently employed at Eli Lilly and Company, where she continues to advance her research in the pharmaceutical industry. Her work has contributed to the development of new therapeutic options for patients suffering from serious health conditions.

Collaborations

Sheila has collaborated with notable colleagues, including Rosanne Bonjouklian and Chafiq Hamdouchi, enhancing the scope and impact of her research through teamwork and shared expertise.

Conclusion

Sheila Pleite Selgas exemplifies the innovative spirit of modern inventors, with her work in kinase inhibitors paving the way for advancements in medical treatments. Her contributions are vital to the ongoing efforts in pharmaceutical research and development.